桥梁铁和肺损伤:铁病在ARDS中的新兴作用
Yuanjun Zhang1, Ji Luo1, Zhiqiang Tang2
1Department of Critical Care Medicine, West China Hospital of Sichuan University-Ziyang Hospital, Ziyang Central Hospital, Ziyang, Sichuan, China.
European journal of medical research
|December 30, 2025
概括
作为细胞死亡途径的铁亡,在急性呼吸困扰综合征 (ARDS) 病原发生过程中至关重要. 了解铁灭的机制为ARDS提供了新的治疗点.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 急性呼吸困难综合征 (ARDS) 是一种严重的炎症性肺损伤,死亡率高,特定疗法有限.
- 铁亡是一种受调节的细胞死亡途径,涉及铁和脂质过氧化,涉及各种疾病.
- 新出现的证据突出显示了铁死在ARDS病变发生过程中的关键作用.
研究的目的:
- 系统地审查不同ARDS病因中的ferroptosis的定义,机制和功能特征.
- 探索铁和ARDS之间的相互作用机制.
- 讨论针对铁亡的干预措施,临床研究,争议以及ARDS的未来前景.
主要方法:
- 系统的文献审查.
- 对铁和ARDS现有的研究进行分析.
- 综合有关机制,干预措施和临床相关性的信息.
主要成果:
- 铁死在ARDS中起着重要作用,在ARDS的不同原因中存在差异.
- 铁和ARDS之间的相互作用机制是复杂的和多方面的.
- 针对铁灭的干预措施显示出ARDS治疗的潜力.
结论:
- 铁化是ARDS病变发生的关键因素,提供了潜在的治疗途径.
- 对ARDS进行进一步的铁灭机制研究和有针对性的干预措施是有必要的.
- 了解铁灭症为开发ARDS新型诊断和治疗策略提供了基础.
相关概念视频
Necrosis
6.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.2K
Acute Respiratory Failure-V
407
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
407
Acute Respiratory Failure-II
974
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
974
Acute Respiratory Failure-I
779
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
779
Acute Respiratory Failure-IV
486
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
486
Acute Respiratory Failure-III
714
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
714


